Diversified Trust’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54M Buy
11,273
+1,122
+11% +$138K 0.02% 353
2026
Q1
$1.2M Sell
10,151
-3,181
-24% -$444K 0.02% 407
2025
Q4
$2.18M Buy
13,332
+1,075
+9% +$168K 0.04% 250
2025
Q3
$1.64M Buy
12,257
+39
+0.3% +$4.74K 0.03% 296
2025
Q2
$1.52M Buy
12,218
+28
+0.2% +$3.56K 0.03% 291
2025
Q1
$1.55M Sell
12,190
-48
-0.4% -$7.39K 0.04% 255
2024
Q4
$1.76M Buy
12,238
+1,769
+17% +$254K 0.04% 251
2024
Q3
$1.56M Buy
10,469
+7,520
+255% +$1.08M 0.04% 268
2024
Q2
$372K Buy
2,949
+106
+4% +$16.6K 0.01% 623
2024
Q1
$523K Sell
2,843
-2,000
-41% -$381K 0.02% 497
2023
Q4
$871K Buy
4,843
+552
+13% +$85.9K 0.03% 327
2023
Q3
$682K Buy
4,291
+1,123
+35% +$184K 0.03% 356
2023
Q2
$448K Buy
3,168
+400
+14% +$64.1K 0.02% 505
2023
Q1
$466K Buy
2,768
+1,050
+61% +$187K 0.02% 487
2022
Q4
$291K Buy
1,718
+583
+51% +$106K 0.01% 599
2022
Q3
$212K Buy
+1,135
New +$239K 0.01% 679
2014
Q2
$250K Buy
+10,954
New +$195K 0.02% 496

Other funds holding RGEN

Diversified Trust's RGEN Position: Q2 2026 in Review

Diversified Trust increased its Repligen (RGEN) stake by 11% in Q2 2026, buying an estimated $138K and bringing the position to 11,273 shares worth $1.54M. The position accounts for 0.02% of the portfolio, ranked #353.

Diversified Trust first reported a position in RGEN in Q2 2014 and has held it in 17 quarters since. The position peaked at $2.18M in Q4 2025. 48 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Diversified Trust held 11,273 shares of Repligen worth $1.54M as of Q2 2026.
  • Diversified Trust bought 1,122 Repligen shares in Q2 2026, an estimated $138K.
  • Repligen made up 0.02% of Diversified Trust's portfolio in Q2 2026, its #353 holding.
  • Diversified Trust first reported a position in Repligen in Q2 2014 and has held it in 17 quarters since.
  • Diversified Trust's Repligen position peaked at $2.18M in Q4 2025.
  • 48 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.